SEE NEW MECHANISM OF ACTION VIDEO FOR PURAPLY® AM

EXPANDING EVIDENCE BASE

Take control with PuraPly® AM—backed by scientific evidence1,2 and multiple peer-reviewed real-world effectiveness studies.3-6

SCIENTIFIC DATA

Discover the antimicrobial barrier effectiveness of PuraPly AM in reducing biofilm-associated bacteria.

SCIENTIFIC DATA 

REAL-WORLD RESULTS

See expanding real-world evidence in large peer-reviewed studies (eg, N=307) that PuraPly AM supports healing in a variety of wound types.

REAL-WORLD RESULTS 

SUPPORT FOR YOU AND YOUR PRACTICE

See how the Organogenesis Circle of Care program can help with billing issues and more, or contact an Organogenesis Tissue Regeneration Specialist to see how PuraPly AM can help your practice.

Contact us

Please refer to the PuraPly AM Instructions for Use for complete prescribing information.

REFERENCES:

  1. Data on file. PDR-0001. Organogenesis Inc.
  2. Davis SC, et al. Int Wound J. 2021. Epub ahead of print. doi:10.1111/iwj.13600
  3. Koullias GJ. Wounds. 2021;33(1):20-27.
  4. Bain MA, et al. J Comp Eff Res. 2020;9(10):691-703. doi:10.2217/cer-2020-0058
  5. Oropallo AR. Plast Reconstr Surg Glob Open. 2019;7:e2047.
  6. Lintzeris D, et al. Wounds. 2018;30(3):72-78.